UBS AM’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-13,179
| Closed | -$1.21M | – | 2893 |
|
|
2021
Q3 | $1.21M | Buy |
13,179
+102
| +0.8% | +$9.35K | ﹤0.01% | 2061 |
|
|
2021
Q2 | $693K | Buy |
13,077
+5,951
| +84% | +$315K | ﹤0.01% | 2399 |
|
|
2021
Q1 | $257K | Buy |
+7,126
| New | +$257K | ﹤0.01% | 2517 |
|
|
2020
Q4 | – | Sell |
-14,148
| Closed | -$707K | – | 2579 |
|
|
2020
Q3 | $707K | Buy |
14,148
+4,500
| +47% | +$225K | ﹤0.01% | 1976 |
|
|
2020
Q2 | $447K | Buy |
+9,648
| New | +$447K | ﹤0.01% | 2167 |
|